- Home
- SVRE vs BDRX Comparison
SVRE vs BDRX Comparison
Compare SVRE & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRE | BDRX |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 4.0M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRE | BDRX |
|---|---|---|
| Price | $1.38 | $2.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 377.1K | ★ 2.8M |
| Earning Date | 12-21-2025 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $580,536.00 | N/A |
| Revenue This Year | $453.30 | N/A |
| Revenue Next Year | $106.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.19 | N/A |
| 52 Week Low | $1.21 | $2.22 |
| 52 Week High | $126.00 | $92.00 |
Technical Indicators
Market Signals| Indicator | SVRE | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 38.94 |
| Support Level | $1.21 | $2.22 |
| Resistance Level | $1.45 | $7.22 |
| Average True Range (ATR) | 0.26 | 0.71 |
| MACD | -0.10 | -0.22 |
| Stochastic Oscillator | 6.64 | 4.60 |
Price Performance
Historical ComparisonAbout SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road and pedestrians. Geographially, it operates in Israel and Europe, out of which it derives maximum revenue from Israel.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.